Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation. | Neurol Sci | 2023 | 36567408 | PubTator, text mining | PubMed |
| Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 | 36539618 | PubTator, text mining | PubMed |
| Mutant MESD links cellular stress to type I collagen aggregation in osteogenesis imperfecta type XX. | Matrix Biol | 2023 | 36526215 | PubTator, text mining | PubMed |
| Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis. | Exp Neurol | 2023 | 36525997 | PubTator, text mining | PubMed |
| Immune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36522170 | PubTator, text mining | PubMed |
| Prognostic predictors of remission in ocular myasthenia gravis. | Acta Neurol Belg | 2023 | 36474006 | PubTator, text mining | PubMed |
| Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis. | Neurol Sci | 2023 | 36469201 | PubTator, text mining | PubMed |
| DOK7 Promotes NMJ Regeneration After Nerve Injury. | Mol Neurobiol | 2023 | 36464749 | PubTator, text mining | PubMed |
| The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis. | Ann Clin Transl Neurol | 2023 | 36453129 | PubTator, text mining | PubMed |
| Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort. | Thorac Cancer | 2023 | 36419347 | PubTator, text mining | PubMed |
| Glycobiology of rheumatic diseases. | Nat Rev Rheumatol | 2023 | 36418483 | PubTator, text mining | PubMed |
| Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol. | JBI Evid Synth | 2023 | 36404752 | PubTator, text mining | PubMed |
| Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis. | J Neurol | 2023 | 36396811 | PubTator, text mining | PubMed |
| New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review. | J Neurol | 2023 | 36352330 | PubTator, text mining | PubMed |
| The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study. | J Neurol | 2023 | 36308527 | PubTator, text mining | PubMed |
| COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis. | Acta Neurol Belg | 2023 | 36279094 | PubTator, text mining | PubMed |
| Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36270951 | PubTator, text mining | PubMed |
| Neurology of cancer immunotherapy. | Neurol Sci | 2023 | 36112276 | PubTator, text mining | PubMed |
| Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study. | Ther Apher Dial | 2023 | 35765859 | PubTator, text mining | PubMed |
| Collision tumors are multiple skin neoplasms at one site (MUSK IN A NEST): a new paradigm for their terminology and classification. | Int J Dermatol | 2023 | 35239975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=33